Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Timeline for development of autologous bone marrow infusion (ABMi) therapy and perspective for future stem cell therapy.
Terai S, Tanimoto H, Maeda M, Zaitsu J, Hisanaga T, Iwamoto T, Fujisawa K, Mizunaga Y, Matsumoto T, Urata Y, Marumoto Y, Hidaka I, Ishikawa T, Yokoyama Y, Aoyama K, Tsuchiya M, Takami T, Omori K, Yamamoto N, Segawa M, Uchida K, Yamasaki T, Okita K, Sakaida I. Terai S, et al. Among authors: mizunaga y. J Gastroenterol. 2012 May;47(5):491-7. doi: 10.1007/s00535-012-0580-5. Epub 2012 Apr 5. J Gastroenterol. 2012. PMID: 22488349 Review.
Granulocyte colony-stimulating factor and interleukin-1β are important cytokines in repair of the cirrhotic liver after bone marrow cell infusion: comparison of humans and model mice.
Mizunaga Y, Terai S, Yamamoto N, Uchida K, Yamasaki T, Nishina H, Fujita Y, Shinoda K, Hamamoto Y, Sakaida I. Mizunaga Y, et al. Cell Transplant. 2012;21(11):2363-75. doi: 10.3727/096368912X638856. Epub 2012 Apr 10. Cell Transplant. 2012. PMID: 22507241 Free article. Clinical Trial.
Status and prospects of liver cirrhosis treatment by using bone marrow-derived cells and mesenchymal cells.
Terai S, Takami T, Yamamoto N, Fujisawa K, Ishikawa T, Urata Y, Tanimoto H, Iwamoto T, Mizunaga Y, Matsuda T, Oono T, Marumoto M, Burganova G, Fernando Quintanilha L, Hidaka I, Marumoto Y, Saeki I, Uchida K, Yamasaki T, Tani K, Taura Y, Fujii Y, Nishina H, Okita K, Sakaida I. Terai S, et al. Among authors: mizunaga y. Tissue Eng Part B Rev. 2014 Jun;20(3):206-10. doi: 10.1089/ten.TEB.2013.0527. Epub 2014 Mar 7. Tissue Eng Part B Rev. 2014. PMID: 24450831 Review.
Administration of fibroblast growth factor 2 in combination with bone marrow transplantation synergistically improves carbon-tetrachloride-induced liver fibrosis in mice.
Ishikawa T, Terai S, Urata Y, Marumoto Y, Aoyama K, Murata T, Mizunaga Y, Yamamoto N, Nishina H, Shinoda K, Sakaida I. Ishikawa T, et al. Among authors: mizunaga y. Cell Tissue Res. 2007 Mar;327(3):463-70. doi: 10.1007/s00441-006-0334-x. Epub 2006 Nov 9. Cell Tissue Res. 2007. PMID: 17093919
Continuous high expression of XBP1 and GRP78 is important for the survival of bone marrow cells in CCl4-treated cirrhotic liver.
Marumoto Y, Terai S, Urata Y, Matsumoto T, Mizunaga Y, Yamamoto N, Jin H, Fujisawa K, Murata T, Shinoda K, Nishina H, Sakaida I. Marumoto Y, et al. Among authors: mizunaga y. Biochem Biophys Res Commun. 2008 Mar 14;367(3):546-52. doi: 10.1016/j.bbrc.2007.12.171. Epub 2008 Jan 7. Biochem Biophys Res Commun. 2008. PMID: 18182158